Valuations of genetic test information for treatable conditions: the case of colorectal cancer screening.

ABSTRACT:

Background

The value of the information that genetic testing services provide can be questioned for insurance-based health systems. The results of genetic tests oftentimes may not lead to well-defined clinical interventions; however, Lynch syndrome, a genetic mutation for which carriers are at an increased risk for colorectal cancer, can be identified through genetic testing, and meaningful health interventions are available via increased colonoscopic surveillance. Valuations of test information for such conditions ought to account for the full impact of interventions and contingent outcomes.

Objectives

To conduct a discrete-choice experiment to elicit individuals' preferences for genetic test information.

Methods

A Web-enabled discrete-choice experiment survey was ad

SUBMITTER: Kilambi V 

PROVIDER: S-EPMC4492688 | biostudies-literature | 2014 Dec

REPOSITORIES: biostudies-literature